However, c-reactive protein (CRP) and aspartate transaminase (AST) expression levels were significantly up-regulated in the MS group, while alanine aminotransferase (ALT) and creatinine levels did not change (Figure S2). The gene discussed is GPT; the disease is myeloid sarcoma.